Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-24-093221
Filing Date
2024-04-11
Accepted
2024-04-11 16:10:56
Documents
4

Document Format Files

Seq Description Document Type Size
1 DEFA14A d500367ddefa14a.htm DEFA14A 11186
2 GRAPHIC g500367g01dsp1.jpg GRAPHIC 9228
3 GRAPHIC g500367g02m00.jpg GRAPHIC 399816
4 GRAPHIC g500367g03a01.jpg GRAPHIC 370809
  Complete submission text file 0001193125-24-093221.txt   1086657
Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Filer) CIK: 0000310158 (see all company filings)

EIN.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-06571 | Film No.: 24838632
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)